Hendrik Liebers
Finance
Probiodrug
Germany
Biography
Hendrik Liebers has been Chief Financial Officer of Probiodrug since 2007. Prior to joining the company as CFO in 2007, Dr Liebers spent nine years with several private equity and venture capital firms with a focus on biotech, pharma, medtech, agro-biotechnology and fund in fund investments. He successfully executed numerous private placements, trade and asset sales, fund in fund investments, mergers and acquisitions as well as licensing and co-development transactions in Europe and the U.S. From 2004 to 2007 he was Head of Life Science at IBG, and was responsible for IBG’s Life Science team and activities. From 1998 to 2004 he held several positions with Corporate Finance Holding GmbH (CFH), lastly as Investment Director. Dr Liebers has served on numerous boards, among them as Vice Chairman of Probiodrug’s supervisory board until 2007. He holds a diploma in economics from University of Leipzig, a diploma of biology from Eberhard Karls University of Tuebingen, and a Dr. rer. med. from the Medical Faculty of the University of Leipzig.
Research Interest
Life Science
